KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.94 $4.15 Friday, 26th Apr 2024 CLRB stock ended at $3.03. This is 0.331% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.69% from a day low at $2.98 to a day high of $3.12.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Apr 12, 2016 $3.88 $4.44 $3.68 $3.72 131 776
Apr 11, 2016 $3.66 $3.99 $3.50 $3.77 209 438
Apr 08, 2016 $4.15 $4.15 $3.50 $3.60 47 612
Apr 07, 2016 $3.75 $4.35 $3.58 $3.80 319 042
Apr 06, 2016 $3.60 $3.82 $3.00 $3.50 104 413
Apr 05, 2016 $3.88 $4.30 $3.47 $3.54 68 541
Apr 04, 2016 $4.35 $5.05 $3.60 $4.07 72 592
Apr 01, 2016 $3.32 $4.87 $3.40 $4.35 184 541
Mar 31, 2016 $3.32 $3.57 $3.31 $3.42 9 515
Mar 30, 2016 $3.53 $3.51 $3.25 $3.40 4 850
Mar 29, 2016 $3.43 $3.77 $3.39 $3.52 5 200
Mar 28, 2016 $3.86 $3.86 $3.36 $3.45 12 100
Mar 24, 2016 $4.07 $4.15 $3.80 $3.96 1 900
Mar 23, 2016 $4.29 $4.29 $4.00 $4.00 9 800
Mar 22, 2016 $4.83 $4.83 $3.94 $4.31 5 800
Mar 21, 2016 $5.05 $5.10 $4.80 $4.96 3 000
Mar 18, 2016 $4.96 $4.96 $4.47 $4.94 2 500
Mar 17, 2016 $4.85 $4.98 $4.80 $4.82 1 300
Mar 16, 2016 $4.92 $5.11 $4.82 $4.90 4 700
Mar 15, 2016 $5.00 $5.12 $4.77 $4.80 7 900
Mar 14, 2016 $5.05 $5.25 $4.81 $5.08 4 900
Mar 11, 2016 $4.90 $5.25 $4.80 $4.80 5 700
Mar 10, 2016 $5.05 $5.26 $4.75 $4.95 9 700
Mar 09, 2016 $4.75 $5.30 $4.75 $4.93 21 200
Mar 08, 2016 $4.75 $4.90 $4.30 $4.63 11 000
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT